Idacta mAb INT-001 represents an interesting therapeutic method for managing specific blood-related cancers. This antigen-binding protein demonstrates a special mode of effect, mainly interacting with the CD38 antigen, https://adamtoib085754.wikipublicity.com/8512414/idacta_mab_int_001_a_innovative_antigen_binding_protein_in_progression